Table 3.
Demographic and clinical characteristics of PLWH by study
| Study | CNICS | PACTOa | RETAINa | Total |
|---|---|---|---|---|
| N | 5195 | 408 | 347 | 5950 |
| Any psy-IPV | 457 (9%) | 71 (17%) | 36 (10%) | 564 (9%) |
| Felt controlled, but not threatened | 194 (4%) | 13 (3%) | 2 (0.6%) | 209 (4%) |
| Felt threatened, but not controlled | 38 (0.7%) | 18 (4%) | 7 (2%) | 63 (1%) |
| Felt both controlled and threatened | 225 (4%) | 40 (10%) | 27 (8%) | 292 (5%) |
| Femaleb | 855 (16%) | 94 (23%) | 124 (36%) | 1073 (18%) |
| Age (mean, SD) | 47 (12) | 46 (9) | 46 (9) | 47 (11) |
| Race/ethnicity | ||||
| White | 2320 (45%) | 1 (0%) | 15 (4%) | 2336 (39%) |
| Black | 1811 (35%) | 0 (0%) | 286 (82%) | 2097 (35%) |
| Hispanic | 779 (15%) | 405 (99%) | 32 (9%) | 1216 (20%) |
| Other/Unknown | 285 (5%) | 2 (0%) | 14 (4%) | 301 (5%) |
| Heterosexual | 1434 (28%) | 348 (85%) | 173 (50%) | 1955 (33%) |
| Men who have sex with men | 3401 (66%) | 41 (10%) | 45 (19%) | 3487 (60%) |
| VL > 400 | 466 (9%) | 192 (47%) | 326 (94%) | 984 (17%) |
| CD4 (mean, SD) | 668 (331) | 540 (346) | 181 (150) | 631 (344) |
| Depression | 926 (18%) | 325 (80%) | 264 (76%) | 1515 (25%) |
| ART use | 4827 (93%) | 297 (73%) | 191 (55%) | 5315 (89%) |
|
ART adherencec (mean %, SD) |
94 (14) | 95 (16) | 90 (21) | 94 (14) |
| Substance Use | ||||
| Methamphetamine/crystal | 446 (9%) | 6 (1%) | 3 (1%) | 455 (8%) |
| Cocaine/crack | 295 (6%) | 230 (56%) | 244 (70%) | 769 (13%) |
| Illicit opioid | 107 (2%) | 186 (46%) | 29 (8%) | 322 (5%) |
| Marijuana | 1514 (29%) | 106 (26%) | 118 (34%) | 1738 (29%) |
| Alcohol | 3319 (64%) | 162 (40%) | 224 (65%) | 3705 (62%) |
| Binge alcohol | 1677 (32%) | 109 (27%) | 158 (46%) | 1944 (33%) |
aPACTO and RETAIN were both STTR studies
bBirth sex
cAdherence defined as % of medication taken in past 30 days
Abbreviations: ARTantiretroviral therapy; IPV intimate partner violence; SD standard deviation; VL viral load